Literature DB >> 2419044

Demonstration of calcitonin and calmodulin by immunoperoxidase in the cystic fibrosis lung.

P Wolf, C Hall, J P Kilbourn.   

Abstract

In this investigation, the presence of calcitonin and calmodulin has been demonstrated in immunoperoxidase formalin-fixed, paraffin-embedded sections of lung from autopsy tissues of four patients who died as a result of complications resulting from their cystic fibrosis disease. Immunoreactive calcitonin has been stained and quantitated in solitary endocrine cells which are increased in number and staining intensity in cystic fibrosis lung when compared to COPD and normal lungs. Immunoreactive calmodulin has been demonstrated to be increased in cystic fibrosis lung when compared to COPD and normal lungs. Previously, increased calcitonin and calmodulin were identified in sputum from cystic fibrosis patients utilizing radioimmunoassay. The calcitonin and calmodulin may be associated with increased calcium in pulmonary secretions leading to selective colonization of the lung by a limited number of pathogenic bacteria and enhanced pulmonary infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419044     DOI: 10.1378/chest.89.3.327

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Phenotypic conversion of Pseudomonas aeruginosa.

Authors:  J P Kilbourn
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

2.  Elevated biliary calmodulin during gallstone formation: the role of bile acids.

Authors:  A J Moser; J A Karam; D I Giurgiu; P A Weber; Z R Abedin; J J Roslyn; M Z Abedin
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

3.  Calmodulin in normal and cystic fibrosis human intestine at different developmental stages.

Authors:  C Rochette-Egly; B Lacroix; H Pflieger; M Doffoel; M Kedinger; K Haffen
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

4.  Pulmonary Sensory Receptors.

Authors:  Inge Brouns; Line Verckist; Isabel Pintelon; Jean-Pierre Timmermans; Dirk Adriaensen
Journal:  Adv Anat Embryol Cell Biol       Date:  2021       Impact factor: 1.231

Review 5.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.